Published in Women's Health Law Weekly, August 14th, 2005
A new drug application (NDA) is expected to be filed as soon as possible after completion of the data analysis, which is projected to be around the end of September.
Bio-E-Gel utilizes Antares Pharma's proprietary Advanced Transdermal Delivery (ATD) gel system, which is designed to allow delivery of hormones and other active ingredients across the skin. Antares...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly